Quick Takeaways
- Hoyoung Huh filed SCHEDULE 13G for Akari Therapeutics, Plc Ordinary Shares, $0.0001 par value (AKTX).
- Disclosed ownership: 16%.
- Date of event: 14 Nov 2024.
Hoyoung Huh - 14 Nov 2024 SCHEDULE 13G Report for Akari Therapeutics, Plc Ordinary Shares, $0.0001 par value (AKTX)
- Filing Manager
- Hoyoung Huh
- Reporting Manager
- Hoyoung Huh, M.D., Ph.D.
- Symbol
- AKTX
- Shares outstanding
- 53,512,954,839 shares
- Disclosed Ownership
- 8,294,508,000 shares
- Ownership
- 16%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Feb 2025, 17:00:04 UTC
- Date of event
- 14 Nov 2024
- Next filing
- 04 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Hoyoung Huh disclosed 16% ownership in Akari Therapeutics, Plc Ordinary Shares, $0.0001 par value (AKTX) on 14 Nov 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 17:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Hoyoung Huh, M.D., Ph.D. | 16% | 8,294,508,000 | 8,294,508,000 | 0 | /s/ Hoyoung Huh | Authorized Person |